Statistics for Rocket Pharmaceuticals (id:6452 RCKT)

Valuation metrics

Market cap

1.27B

Enterprise value

1.06B

Trailing P/E (ttm)

-4.83

Forward P/E

-5.34

PEG ratio

-5.34

Price/Sales (ttm)

Price/Book (mrq)

3.86

Enterprise Value/Revenue

Enterprise Value/EBITDA

-4.02

Overview

Shares outstanding

91.16M

Float

71.07M

Shares short

11.90M

% Held by insiders

0.03%

% Held by institutions

1.06%

Average volume (10 days)

901.07K

Average volume (90 days)

Price summary

52-Week low

12.62

52-Week high

32.52

52-Week change

-57.69%

Beta

1.09

50-Day moving average

17.75

200-Day moving average

22.21

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

January 05th, 2018

Ex-dividend date

Last split factor

2:1

Last split date

January 05th, 2018

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-34.48%

Return on equity

-59.27%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-264,840,992.00

Net income to common (ttm)

-258,079,008.00

Diluted EPS (ttm)

-2.73

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

235.66M

Total cash per share (mrq)

2.58

Total debt (mrq)

25.64M

Total Debt/Equity (mrq)

7.78

Current ratio (mrq)

604.70%

Book value per share (mrq)

3.62

Cash flow

Cash flow statement

-192,120,992.00

Levered free cash flow (LFCF)

-120,673,624.00